An Overview on Beta Vulgaris: Its Functions as Antidyslipidemia Yulia Rohman (a*), Arief Nurudhin (b), Lusi Oka Wardhani (b)
a) Department of Nutrition Science Universitas Sebelas Maret, Surakarta, Indonesia
b) Internal Medicine Department Faculty of Medicine Universitas Sebelas Maret, Surakarta, Indonesia
Abstract
Dyslipidemia is a dysfuntion of lipoprotein metabolism indicated by elevated total cholesterol, low density lipoprotein cholesterol and triglyceride as well as lowering high density lipoprotein cholesterol in serum. Beta vulgaris is a rich source of nutrients such as vitamins, minerals, proteins, and a variety of bioactive phenolic substances that are primarily composed of betalains, and other components with antioxidant activity including flavonoids (viteixin, rutin, apigenin, quercetin, orientin), coumarins, carotenoids, and triterpenes. In order for Beta vulgaris to be effective in treating dyslipidemia, it must be able to upregulate antioxidant, inhibit LDL mediated oxidative effect on endothelial cells, and minimiza metabolic abnormalities in rats fed a dyslipidemia diet. A systematic review of research was conducted covering Scopus, PubMed, Cochrane Database and Google scholar in English. The purpose of this review is to focus on nutraceutical facts of Beta vulgaris by focusing on the alternative treatment to future dyslipidemia.
Keywords: Beta vulgaris- Dyslipidemia- Treatment
Topic: Medical : basic science, clinical, translational research, medical education, and miscellaneous
